CIK 0000882796 · Large accelerated filer
BIOCRYST PHARMACEUTICALS INC
Sign in to watch- Ticker
- BCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 621413174
- Phone
- 919-859-1302
- Business address
- 4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-11 | McKee Amy E Director | Grant or award · Automatic Stock Option Grant | +33,540 | 33,540 | ||
| 2026-06-11 | HEGGIE THERESA Director | Grant or award | +15,294 | 80,646 | ||
| 2026-06-11 | HEGGIE THERESA Director | Grant or award · Automatic Stock Option Grant | +33,540 | 33,540 | ||
| 2026-05-29 | Milne Jill C. Director | Grant or award | +1,262 | $8.91 | $11K | 16,644 |
| 2026-05-29 | Stonehouse Jon P Director | Grant or award | +631 | $8.91 | $6K | 1,324,481 |
| 2026-05-29 | McKee Amy E Director | Grant or award | +631 | $8.91 | $6K | 31,883 |
| 2026-05-29 | MILANO VINCENT Director | Grant or award | +1,122 | $8.91 | $10K | 93,189 |
| 2026-05-29 | Frank Steven Director | Grant or award | +1,262 | $8.91 | $11K | 20,165 |
| 2026-05-18 | McKee Amy E Director | Sale | −11,180 | $8.97 | $100K | 31,252 |
| 2026-05-13 | Barnes Alane P Chief Legal Officer | Option exercise 10b5-1 | +62,500 | $5.04 | $315K | 463,203 |
| 2026-05-13 | Barnes Alane P Chief Legal Officer | Sale 10b5-1 | −62,500 | $9.54 | $596K | 400,703 |
| 2026-05-13 | Barnes Alane P Chief Legal Officer | Option exercise · Emp. Stock Option (Right to Buy) 10b5-1 | −62,500 | 0 | ||
| 2026-04-06 | Menon Sandeep Chief R&D Officer | Grant or award | +205,150 | 205,150 | ||
| 2026-04-06 | Menon Sandeep Chief R&D Officer | Grant or award · Emp. Stock Option (Right to Buy) | +441,350 | 441,350 | ||
| 2026-03-20 | HEGGIE THERESA Director | Option exercise | +49,933 | $6.30 | $315K | 115,285 |
| 2026-03-20 | HEGGIE THERESA Director | Sale | −49,933 | $10.11 | $505K | 65,352 |
| 2026-03-20 | HEGGIE THERESA Director | Option exercise · Automatic Stock Option Grant | −49,933 | 0 | ||
| 2026-03-16 | Barnes Alane P Chief Legal Officer | Option exercise 10b5-1 | +150,000 | $5.51 | $827K | 550,703 |
| 2026-03-16 | Barnes Alane P Chief Legal Officer | Sale 10b5-1 | −150,000 | $9.15 | $1.4M | 400,703 |
| 2026-03-16 | Barnes Alane P Chief Legal Officer | Option exercise · Emp. Stock Option (Right to Buy) 10b5-1 | −150,000 | 0 |
Page 2 of 18 · 357 trades